T1	Participants 71 106	advanced non-small-cell lung cancer
T2	Participants 413 448	advanced non-small-cell lung cancer
T3	Participants 513 671	202 academic medical centres in 24 countries. Patients with previously treated non-small-cell lung cancer with PD-L1 expression on at least 1% of tumour cells
T4	Participants 1319 1345	we enrolled 1034 patients: